Market Cap
US$1.4b
Last Updated
2019/10/16 23:34 UTC
Data Sources
Company Financials
Executive Summary
CorVel Corporation provides workers’ compensation solutions for employers, third party administrators, insurance companies, and government agencies seeking to control costs and promote positive outcomes.
Snowflake
Fundamentals
Flawless balance sheet with solid track record.
Similar Companies
Share Price & News
How has CorVel's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
2.1%
CRVL
4.6%
US Healthcare
2.3%
US Market
1 Year Return
39.3%
CRVL
-8.5%
US Healthcare
5.6%
US Market
Return vs Industry: CRVL exceeded the US Healthcare industry which returned -8.5% over the past year.
Return vs Market: CRVL exceeded the US Market which returned 5.6% over the past year.
Shareholder returns
| CRVL | Industry | Market | |
|---|---|---|---|
| 7 Day | 2.1% | 4.6% | 2.3% |
| 30 Day | -2.6% | -0.1% | -1.0% |
| 90 Day | -14.5% | -4.5% | -0.7% |
| 1 Year | 39.3%39.3% | -7.1%-8.5% | 7.9%5.6% |
| 3 Year | 122.1%122.1% | 31.9%26.5% | 45.6%36.3% |
| 5 Year | 139.6%139.6% | 63.7%53.9% | 65.8%47.6% |
Price Volatility Vs. Market
How volatile is CorVel's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 days ago | Simply Wall St
A Closer Look At CorVel Corporation's (NASDAQ:CRVL) Impressive ROE2 weeks ago | Simply Wall St
A Look At The Fair Value Of CorVel Corporation (NASDAQ:CRVL)4 weeks ago | Simply Wall St
What Does CorVel Corporation's (NASDAQ:CRVL) P/E Ratio Tell You?Valuation
Is CorVel undervalued compared to its fair value and its price relative to the market?
5.6%
Undervalued compared to fair value
Share Price vs. Fair Value
Undervalued: CRVL ($78.23) is trading below our estimate of fair value ($82.84)
Significantly Undervalued: CRVL is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: CRVL is poor value based on its PE Ratio (30.3x) compared to the Healthcare industry average (20.3x).
PE vs Market: CRVL is poor value based on its PE Ratio (30.3x) compared to the US market (17.7x).
Price to Earnings Growth Ratio
Low PEG Ratio: Insufficient data to calculate CRVL's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CRVL is overvalued based on its PB Ratio (7.1x) compared to the US Healthcare industry average (2.5x).
Next Steps
Future Growth
How is CorVel forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
3.1%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CRVL's forecast earnings growth (3.1% per year) is above the savings rate (2.7%).
Earnings vs Market: CRVL's earnings (3.1% per year) are forecast to grow slower than the US market (14.5% per year).
High Growth Earnings: CRVL's earnings are forecast to grow, but not significantly.
Revenue vs Market: Insufficient data to determine if CRVL's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if CRVL's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
High Future ROE: Insufficient data to determine if CRVL's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has CorVel performed over the past 5 years?
9.6%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: CRVL's earnings have grown by 9.6% per year over the past 5 years.
Accelerating Growth: CRVL's earnings growth over the past year (24.9%) exceeds its 5-year average (9.6% per year).
Earnings vs Industry: CRVL earnings growth over the past year (24.9%) exceeded the Healthcare industry 5.3%.
Return on Equity
High ROE: CRVL's Return on Equity (23.7%) is considered high.
Return on Assets
ROA vs Industry: CRVL has a higher Return on Assets than the Healthcare industry average last year.
Return on Capital Employed
ROCE Improving: CRVL's Return on Capital Employed has declined over the past 3 years.
Next Steps
Financial Health
How is CorVel's financial position?
Financial Position Analysis
Short Term Liabilities: CRVL's short term assets ($221.6M) exceeds its short term liabilities ($130.7M)
Long Term Liabilities: CRVL's short term assets (221.6M) exceeds its long term liabilities (93.3M)
Debt to Equity History and Analysis
Debt Level: CRVL is debt free.
Reducing Debt: CRVL has not had any debt for past 5 years.
Debt Coverage: CRVL has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: CRVL has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Inventory Level: CRVL has a high level of physical assets or inventory.
Debt Coverage by Assets: Insufficient data to determine if CRVL's debt is covered by short term assets.
Next Steps
Dividend
What is CorVel's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: Unable to evaluate CRVL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate CRVL's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stable Dividend: Insufficient data to determine if CRVL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CRVL's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CRVL's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
What is the CEO of CorVel's salary, the management and board of directors tenure and is there insider trading?
2.9yrs
Average management tenure
CEO
Michael Combs (55yo)
0.8yrs
Tenure
US$1,770,006
Compensation
Mr. Michael G. Combs has been as the President of CorVel Corporation since April 1, 2017 and has been its Chief Executive Officer since January 18, 2019. Mr. Combs Chief Information Officer at CorVel Corp ...
CEO Compensation Analysis
Compensation vs. Market: Michael has recently become CEO, making it difficult to compare their total compensation against companies of similar size in the US market.
Compensation vs Earnings: Michael's compensation has increased by more than 20% in the past year.
Management Age and Tenure
2.9yrs
Average Tenure
51.5yo
Average Age
Experienced Management: CRVL's management team is considered experienced (2.9 years average tenure).
Board Age and Tenure
28.4yrs
Average Tenure
71yo
Average Age
Experienced Board: CRVL's board of directors are seasoned and experienced ( 28.4 years average tenure).
Insider Trading
Insider Buying: CRVL insiders have only sold shares in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Role | Chairman of the Board Chairman & COO |
| Shares | 2,000 |
| Max Price | US$86.13 |
| Entity | Individual |
| Role | Chairman of the Board Chairman & COO |
| Shares | 1,000 |
| Max Price | US$85.63 |
| Entity | Individual |
| Role | Chairman of the Board Chairman & COO |
| Shares | 3,000 |
| Max Price | US$85.29 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 117 |
| Max Price | US$86.00 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 3,673 |
| Max Price | US$86.09 |
| Entity | Individual |
| Role | Chairman of the Board Chairman & COO |
| Shares | 1,000 |
| Max Price | US$85.45 |
| Entity | Individual |
| Role | Chairman of the Board Chairman & COO |
| Shares | 4,000 |
| Max Price | US$86.03 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 5,046 |
| Max Price | US$86.50 |
| Entity | Individual |
| Role | Chairman of the Board Chairman & COO |
| Shares | 3,000 |
| Max Price | US$88.15 |
| Entity | Individual |
| Role | Head of Marketing Chief Marketing Officer |
| Shares | 1,000 |
| Max Price | US$81.75 |
| Entity | Individual |
| Role | Chairman of the Board Chairman & COO |
| Shares | 5,566 |
| Max Price | US$82.94 |
| Entity | Individual |
| Role | Chief Financial Officer Chief Financial Officer |
| Shares | 1,015 |
| Max Price | US$74.41 |
| Entity | Individual |
| Role | Chief Executive Officer President & CEO |
| Shares | 1,350 |
| Max Price | US$74.00 |
| Entity | Individual |
| Role | Lead Director Lead Independent Director |
| Shares | 4,859 |
| Max Price | US$74.02 |
| Entity | Individual |
| Role | Chairman of the Board Chairman & COO |
| Shares | 3,000 |
| Max Price | US$74.83 |
| Entity | Individual |
| Role | Chairman of the Board Chairman & COO |
| Shares | 1,000 |
| Max Price | US$66.35 |
| Entity | Individual |
| Role | Lead Director Lead Independent Director |
| Shares | 3,000 |
| Max Price | US$66.14 |
| Entity | Individual |
| Role | Chairman of the Board Chairman & COO |
| Shares | 1,700 |
| Max Price | US$65.83 |
| Entity | Individual |
| Role | Chairman of the Board Chairman & COO |
| Shares | 2,200 |
| Max Price | US$65.24 |
| Entity | Individual |
| Role | Chairman of the Board Chairman & COO |
| Shares | 4,700 |
| Max Price | US$65.48 |
| Entity | Individual |
| Role | Chairman of the Board Chairman & COO |
| Shares | 722 |
| Max Price | US$64.52 |
| Entity | Individual |
| Role | Chairman of the Board Chairman & COO |
| Shares | 2,600 |
| Max Price | US$65.40 |
| Entity | Individual |
| Role | Chairman of the Board Chairman & COO |
| Shares | 3,000 |
| Max Price | US$63.81 |
Ownership Breakdown
Management Team
Richard Schweppe (64yo)
Secretary
- Tenure: 24.3yrs
- Compensation: US$223.00k
Victor Clemons (75yo)
Chairman & COO
- Tenure: 28.5yrs
- Compensation: US$401.01k
Diane Blaha (64yo)
Chief Marketing Officer
- Tenure: 2.9yrs
- Compensation: US$703.75k
Sharon O'Connor
Vice President of Legal & Human Resources
- Tenure: 3.5yrs
Michael Combs (55yo)
President & CEO
- Tenure: 0.8yrs
- Compensation: US$1.77m
Michael Saverien (48yo)
Executive Vice President of Risk Management Services
- Tenure: 2.5yrs
- Compensation: US$669.24k
Maxim Shishin (44yo)
Chief Information Officer
- Tenure: 2.5yrs
- Compensation: US$523.51k
Stefani Wendel
Investor Relation
- Tenure: 0yrs
Jennifer Yoss (41yo)
Vice President of Accounting
- Tenure: 5.3yrs
- Compensation: US$251.78k
Brandon O’Brien (39yo)
Chief Financial Officer
- Tenure: 1yrs
- Compensation: US$498.54k
Board Members
Steve Hamerslag (62yo)
Independent Director
- Tenure: 28.4yrs
- Compensation: US$81.24k
Victor Clemons (75yo)
Chairman & COO
- Tenure: 28.5yrs
- Compensation: US$401.01k
Jeff Michael (62yo)
Independent Director
- Tenure: 29.1yrs
- Compensation: US$77.24k
R. Jessup (71yo)
Lead Independent Director
- Tenure: 0yrs
- Compensation: US$87.24k
Alan Hoops (71yo)
Independent Director
- Tenure: 16.4yrs
- Compensation: US$80.24k
Jean Macino (76yo)
Independent Director
- Tenure: 11.7yrs
- Compensation: US$78.42k
Company Information
CorVel Corporation's company bio, employee growth, exchange listings and data sources
Key Information
- Name: CorVel Corporation
- Ticker: CRVL
- Exchange: NasdaqGS
- Founded: 1987
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: US$1.445b
- Shares outstanding: 18.47m
- Website: https://www.corvel.com
Number of Employees
Location
- CorVel Corporation
- 2010 Main Street
- Suite 600
- Irvine
- California
- 92614
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| CRVL | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Jun 1991 |
Biography
CorVel Corporation provides workers’ compensation solutions for employers, third party administrators, insurance companies, and government agencies seeking to control costs and promote positive outcomes. I ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/16 23:34 |
| End of Day Share Price | 2019/10/16 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2019/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.